Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear

Submitted by admin on February 10, 2021 - 10:16am
Source: 
Fierce Pharma
News Tags: 
Eli Lilly
COVID-19
antibodies
FDA
Emergency Use Authorization
Headline: 
Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear
snippet: 

Two weeks after Eli Lilly unveiled data showing its COVID-19 antibody cocktail of bamlanivimab and etesevimab slashed the risk of death and hospitalization for high-risk patients, the cocktail has won its emergency FDA authorization.

Do Not Allow Advertisers to Use My Personal information